Furthermore, topo I-reactive B cells were adoptively transferred with either anti-IL-6 (1 mg/week, administrated subcutaneously) or anti-IL-23 (100 μg/week, administrated subcutaneously) antibodies (Abs), and dermal thickness and lung fibrosis score were examined 14 days after the adoptive transfer (E). This evidence concerns the gene IL23A and pulmonary fibrosis.